1
van't Klooster, TM, de Ridder, Maria, Kemmeren, JM, Lei, Johan, Dekker, Francois, Sturkenboom, MCJM, de Melker, HE
Veröffentlicht in: van't Klooster , TM , de Ridder , M , Kemmeren , JM , Lei , J , Dekker , F , Sturkenboom , MCJM & de Melker , HE 2015 , ' Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands ' , European Journal of Pediatrics , vol. 174 , no. 5 , pp. 641-649 . https://doi.org/10.1007/s00431-014-2444-x;
2015
Veröffentlicht in: van't Klooster , TM , de Ridder , M , Kemmeren , JM , Lei , J , Dekker , F , Sturkenboom , MCJM & de Melker , HE 2015 , ' Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands ' , European Journal of Pediatrics , vol. 174 , no. 5 , pp. 641-649 . https://doi.org/10.1007/s00431-014-2444-x;
2015
2
Vermeer-de Bondt, PE, Schoffelen, T, Vanrolleghem, Ann, Isken, LD, van Deuren, M, Sturkenboom, MCJM, Timen, A
Veröffentlicht in: Vermeer-de Bondt , PE , Schoffelen , T , Vanrolleghem , A , Isken , LD , van Deuren , M , Sturkenboom , MCJM & Timen , A 2015 , ' Coverage of the 2011 Q Fever Vaccination Campaign in the Netherlands, Using Retrospective Population-Based Prevalence Estimation of Cardiovascular Risk-Conditions for Chronic Q Fever ' , PLoS One (print) , vol. 10 , no. 4 . https://doi.org/10.1371/journal.pone.0123570;
2015
Veröffentlicht in: Vermeer-de Bondt , PE , Schoffelen , T , Vanrolleghem , A , Isken , LD , van Deuren , M , Sturkenboom , MCJM & Timen , A 2015 , ' Coverage of the 2011 Q Fever Vaccination Campaign in the Netherlands, Using Retrospective Population-Based Prevalence Estimation of Cardiovascular Risk-Conditions for Chronic Q Fever ' , PLoS One (print) , vol. 10 , no. 4 . https://doi.org/10.1371/journal.pone.0123570;
2015
3
Wijnans, L, Dieleman, Jeanne, Voordouw, B, Sturkenboom, MCJM
Veröffentlicht in: Wijnans , L , Dieleman , J , Voordouw , B & Sturkenboom , MCJM 2013 , ' Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands ' , PLoS One (print) , vol. 8 , no. 4 . https://doi.org/10.1371/journal.pone.0063156;
2013
Veröffentlicht in: Wijnans , L , Dieleman , J , Voordouw , B & Sturkenboom , MCJM 2013 , ' Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands ' , PLoS One (print) , vol. 8 , no. 4 . https://doi.org/10.1371/journal.pone.0063156;
2013